Joshua H. Bilenker, President & CEO at Loxo Oncology, Inc. (LOXO), sold 10,000 shares at $157.67 ($1.6M) on 2018-08-13, disclosed to the SEC on 2018-08-15.
Open-market sale of $1.6M LOXO by President & CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $157.67 | 1,600 | $252K | 15.9% |
| 2 | $158.51 | 4,233 | $671K | 42.2% |
| 3 | $159.63 | 3,367 | $537K | 33.8% |
| 4 | $160.49 | 800 | $128K | 8.1% |
| Total | $158.91 avg | 10,000 | $1.6M | 100% |
| Filing → |
| LOXO | SELL | 2018-12-12 | $2.7M | — | Filing → |
| LOXO | SELL | 2018-12-12 | $1.0M | — | Filing → |
| LOXO | SELL | 2018-11-28 | $1.2M | — | Filing → |